NVEC's Q1 results reflect strong revenue growth, higher earnings, and momentum from new products, robotics and AIoT opportunities.
NVE Corporation (NVEC) Q1 2027 Earnings Call Transcript
NVE NASDAQ: NVEC reported a sharp increase in revenue and earnings for the quarter ended June 30, 2026, with management citing higher product sales, new products and a stronger semiconductor market as key drivers.
NVEC appears to be at a key inflection point.
NVE earns an "Outperform" upgrade as defense sales recover, manufacturing expansion concludes, and strong momentum in AIoT, robotics and medical-device markets fuels growth prospects.
NVE reports a 27% increase in Q4 net income, driven by strong product sales and an optimistic outlook for growth in the semiconductor and robotics markets.
NVE Corp's niche model, debt-free balance sheet, and lower valuation give it a risk-adjusted edge over Alpha and Omega despite slower growth prospects.
NVEC reports strong quarterly results, with revenue and earnings growth driven by higher product sales, contract R&D strength and improving end-market demand.
NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript
NVEC's Q2 revenues and profit decline y/y, but rising non-defense sales and new products signal improving growth momentum.
NVE Corporation (NASDAQ:NVEC ) Q2 2026 Earnings Call October 22, 2025 5:00 PM EDT Company Participants Daniel Baker - CEO, President & Director Daniel Nelson - Accounting Manager & Principal Financial Officer and Controller Peter Eames - Vice President of Advanced Technology Conference Call Participants Jeffrey Bernstein - Cowen Inc. Presentation Daniel Baker CEO, President & Director Good afternoon, and welcome to the NVE Corporation Conference Call for the quarter ended September 30, 2025. The I'm Dan Baker, NVE's President and CEO.
NVE Corporation's spintronics deliver ultra-low-power sensors and isolators. This is how they can sustain high margins and a steady dividend. NVE has also focused on CAPEX for its WLCSP capacity. The new WLCSP ADLxxx-20E nanoswitches open several new potential use cases. For example, new revenue verticals could come with medical, IoT, and robotics niches for its WLCSP family line.